Map | A Partnership for Children's Health Search:  Advanced Search
Home General Information Country Support Board Task Forces Resources Media Center
About the alliance The Vaccine Fund Immunization information
Economic Impact Diseases & Vaccines Injection Safety Resources
Printer-friendly format

Quick Reference:

What is GAVI?

Questions & Answers

Governance

Board Documents

Guidelines & Forms

Press Releases

Immunization Information

Immunization Focus
Latest Issue

GAVI Update

Disease Information

Information brève en Français

Neisseria (N.) meningitidis (copyright Aventis)

Meningococcus

Group A and C meningococci: Neisseria (N.) meningitidis group A is the cause of major epidemics in sub-Saharan Africa, with thousands of cases per outbreak and a case fatality rate of about 10 %.

Between 1988 and 1997, 704,000 cases of meningitis and 100,000 deaths were reported in the so-called "African meningitis belt," which stretches from Ethiopia in East Africa to The Gambia in the west. The largest recorded epidemic, with more than 200,000 cases and 20,000 deaths reported, occurred in 1996. These reports typically substantially underestimate the actual burden of the disease. During epidemics, routine reporting systems break down, many patients die before reaching a health center, and the cause of death goes unrecorded.

Epidemic meningitis attacks a broad age range, with young people at particular risk. Infants less than a year old are most at risk. Infection is characterized by high fever, vomiting, and confusion, which can progress over several hours to death. Despite antibiotic therapy, at least one in 10 with the disease will die, and another 10 percent are left with neurologic disorders and the loss of the use of their limbs through paralysis. Untreated, up to 50 percent of cases result in death.

Currently used polysaccharide vaccines are not effective in inducing protection in infants and can only be used in expensive and disruptive emergency interventions in older children. Therefore, the overall goal is to develop a (conjugate) vaccine to be incorporated into routine immunization programs in areas at risk of epidemics.

At a glance

Vaccine-preventable disease statistics

Glossaire des infections a prévention vaccinale

'Traditional' or 'basic' vaccines

Under-used vaccines

Vaccines that are expected to be available shortly

Other vaccines

Vaccines for which more research is needed

  Contact us | Guestbook | Copyrights | Text site